Medicare GLP-1 Bridge: Who Qualifies for $50 Wegovy, Zepbound and Foundayo (2026)
September 24, 2026
By Dan Brown · Published September 24, 2026 For years, the standard answer was that Medicare doesn’t cover weight-loss drugs....
Read moreFoundayo vs. Wegovy Pill: What Each One Really Costs Per Month (2026)
September 23, 2026
By Dan Brown · Published September 23, 2026 · Prices checked September 23, 2026 Foundayo vs. Wegovy Pill: What Each...
Read moreSemaglutide vs. Tirzepatide: Which GLP-1 Is Right for You?
September 21, 2026
By Dan Brown · Published September 21, 2026 If you’re trying to decide between semaglutide and tirzepatide, you’re probably seeing...
Read moreFDA Update on Compounded GLP-1 Medications: What You Need to Know
September 17, 2026
By Dan Brown · Published September 17, 2026 Article at a Glance The FDA says the shortages of semaglutide and...
Read moreWhat Happens If I Want to Cancel My GLP-1 Provider?
September 16, 2026
By Dan Brown · Published September 16, 2026 Quick Answer: Before you cancel GLP-1 provider services, first find out exactly...
Read moreWhich GLP-1 Providers Require a Monthly Membership?
September 15, 2026
By Dan Brown · Published September 15, 2026 Quick Answer: GLP-1 provider membership fees vary depending on how each telehealth...
Read moreMy Insurance Stopped Covering My GLP-1. Now What?
September 14, 2026
By Dan Brown · Published September 14, 2026 If your insurance stopped covering your GLP-1, you’re probably wondering what you’re...
Read moreWhat Is a “GLP-3” — and Is It Better Than a GLP-1?
September 14, 2026
By Dan Brown · Published September 14, 2026 GLP-3 vs GLP-1 sounds like a simple comparison. You’ve probably heard about...
Read moreI Reached My Goal Weight on a GLP-1. Now What?
September 12, 2026
By Dan Brown · Published September 12, 2026 Reaching your goal weight on a GLP-1 can feel like crossing the...
Read moreWhat Happens When You Stop Taking a GLP-1?
September 11, 2026
By Dan Brown · Published September 11, 2026 Article at a Glance Weight regain after stopping a GLP-1 is common,...
Read more